Last update 01 Nov 2024

Kowa Yakutsu Y.K.

Japan

Overview

Tags

Other Diseases
Nervous System Diseases
Digestive System Disorders
Herbal medicine

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
no Data
No Data
Disease DomainCount
Nervous System Diseases13
Infectious Diseases7
Hemic and Lymphatic Diseases4
Immune System Diseases4
Endocrinology and Metabolic Disease3
Neoplasms1
Top 5 Drug TypeCount
Herbal medicine22

Related

22
Drugs associated with Kowa Yakutsu Y.K.
Guipi Decoction
Target-
Mechanism-
Active Org.
Kowa Yakutsu Y.K.
Originator Org.
Kowa Yakutsu Y.K.
Active Indication
Anemia
Inactive Indication-
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
JP
First Approval Date25 Jul 1987
Xionggui Jiaoai Decoction
Target-
Mechanism-
Active Org.
Kowa Yakutsu Y.K.
Originator Org.
Kowa Yakutsu Y.K.
Active Indication
Hemorrhage [+1]
Inactive Indication-
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
JP
First Approval Date30 Oct 1986
Shaoyao Gancao
Target-
Mechanism-
Active Org.
Kowa Yakutsu Y.K.
Originator Org.
Kowa Yakutsu Y.K.
Active Indication
Muscle Spasticity
Inactive Indication-
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
JP
First Approval Date09 Sep 1986
100 Clinical Results associated with Kowa Yakutsu Y.K.
Login to view more data
0 Patents (Medical) associated with Kowa Yakutsu Y.K.
Login to view more data
100 Deals associated with Kowa Yakutsu Y.K.
Login to view more data
100 Translational Medicine associated with Kowa Yakutsu Y.K.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 22 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Approved
22
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Xionggui Jiaoai Decoction
Hemorrhage
More
Approved
Liuwei Dihuang Pills
Pollakisuria
More
Approved
Wen Qing Yin
Andropause
More
Approved
Jiawei Xiaoyao San
Menstruation Disturbances
More
Approved
Banxia Houpo Decoction
Cough
More
Approved
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free